The possibility that the reduction in E-cadherin seen in metastatic breast cancer cells is functionally related to the upregulation of c-Jun implies that there too, the increase is not transcriptionally but rather post-transcriptionally controlled. Here, CDH1 is linked to breast carcinoma.